Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06079619
What this trial is testing

Comparison of Dermatoscopy X400 Interpreted by 6 Non-dermatologists and an Artificial Intelligence Software Skin Artificial Intelligence Versus Dermatoscopy x 20

Who this might be right for
Genital TumorPigmented Lesions
Centre Hospitalier Universitaire de Saint Etienne 157
Not applicableUnknownNCT02585219
What this trial is testing

Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas

Who this might be right for
Glioblastoma
University Medical Center Groningen 10
Testing effectiveness (Phase 2)Ended earlyNCT07012330
What this trial is testing

Comparing 177Lu-Dotatate/Capecitabine Combination Treatment With 177Lu-Dotatate in Neuroendocrine Tumor Patients

Who this might be right for
Neuroendocrine (NE) Tumors
Erasmus Medical Center 111
Testing effectiveness (Phase 2)Study completedNCT03617328
What this trial is testing

Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 33
Early research (Phase 1)Study completedNCT00967577
What this trial is testing

177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors

Who this might be right for
Kidney CancerHead and Neck CancerBreast Cancer+6 more
Weill Medical College of Cornell University 20
Testing effectiveness (Phase 2)Study completedNCT00831545
What this trial is testing

Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)

Who this might be right for
Metastases of Central Nervous SystemMelanomaBreast Neoplasm+1 more
Merck Sharp & Dohme LLC 162
Early research (Phase 1)Study completedNCT02529072
What this trial is testing

Nivolumab With DC Vaccines for Recurrent Brain Tumors

Who this might be right for
Malignant GliomaAstrocytomaGlioblastoma
Gary Archer Ph.D. 6
Testing effectiveness (Phase 2)Study completedNCT00338130
What this trial is testing

Randomised Study to Compare the Efficacy of AZD6244 vs TMZ

Who this might be right for
Melanoma
AstraZeneca 239
Large-scale testing (Phase 3)WithdrawnNCT00334867
What this trial is testing

Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma

Who this might be right for
Sarcoma
Children's Oncology Group
Very early researchLooking for participantsNCT04135807
What this trial is testing

Implantable Microdevice In Primary Brain Tumors

Who this might be right for
Grade II GliomaGrade III GliomaGrade IV Glioma+5 more
Oliver Jonas 12
Testing effectiveness (Phase 2)Study completedNCT01242631
What this trial is testing

Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer

Who this might be right for
Testicular CancerGerm Cell Cancer
Hannover Medical School 25
Not applicableStudy completedNCT05140902
What this trial is testing

Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom

Who this might be right for
Glioblastoma
University of Alabama at Birmingham 12
Large-scale testing (Phase 3)Ended earlyNCT00796445
What this trial is testing

A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor

Who this might be right for
Melanoma
GlaxoSmithKline 1,351
Early research (Phase 1)Active Not RecruitingNCT04808245
What this trial is testing

Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas

Who this might be right for
Newly Diagnosed H3-mutated Glioma
German Cancer Research Center 15
Testing effectiveness (Phase 2)Ended earlyNCT03361228
What this trial is testing

Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 5
Early research (Phase 1)Study completedNCT00509353
What this trial is testing

N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 26
Testing effectiveness (Phase 2)UnknownNCT03374839
What this trial is testing

Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients

Who this might be right for
Melanoma
Nantes University Hospital 11
Not applicableActive Not RecruitingNCT00639301
What this trial is testing

Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life

Who this might be right for
Retinoblastoma
Memorial Sloan Kettering Cancer Center 473
Not applicableStudy completedNCT00025012
What this trial is testing

Isotretinoin in Preventing Skin Cancer

Who this might be right for
Melanoma (Skin)Non-melanomatous Skin Cancer
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Next Page